Stimulation of tissue type plasminogen activator by leukaemic cell homogenates.
In patients with disseminated intravascular coagulation (DIC), hyperfibrinolysis was observed in patients with leukaemia, but hypofibrinolysis was seen in those with sepsis. Although the plasma tissue plasminogen activator (t-PA) level was higher in patients with DIC than in those without DIC, there was no significant difference in t-PA level between the patients with leukaemia and sepsis. Hyperfibrinolysis might not be caused by t-PA derived from leukaemic cells, although the PA antigen level in leukaemic cell homogenates was significantly higher in patients with DIC than in those without DIC. The activation of t-PA by leukaemic cell homogenates in the absence of bromocyan fibrinogen fragments suggested that leukaemic cell homogenates had t-PA stimulator activity. The t-PA stimulator activity was high in both acute myeloblastic leukaemia (AML) and acute lymphoblastic leukaemia (ALL), especially in DIC, but this activity was not detected in chronic myelocytic leukaemia (CML) or normal cells. Since fibrinogen and soluble fibrin monomer complex levels in leukaemic cells were also high in patients with DIC, fibrinogen degradation products might be the major t-PA stimulator in leukaemic cells. This might be one of the causes of hyperfibrinolysis in leukaemia.
Wada
H
H
Second Department of Internal Medicine, Mie University School of Medicine, Japan.
Kumeda
Y
Y
Ogasawara
Z
Z
Minamikawa
K
K
Wakita
Y
Y
Nakase
T
T
Kaneko
T
T
Ohiwa
M
M
Kageyama
S
S
Kobayashi
T
T
D014408:Biomarkers, Tumor / Q000097:blood; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000209:etiology; D004789:Enzyme Activation; D005342:Fibrinolysis / Q000502:physiology*; D006487:Hemostasis / Q000502:physiology*; D006801:Humans; D007938:Leukemia / Q000097:blood* / Q000150:complications; D010959:Tissue Plasminogen Activator / Q000097:blood*
D014408:Biomarkers, Tumor; D010959:Tissue Plasminogen Activator